Keyphrases
Transgenic Mice
100%
Endothelial Activation
100%
Therapeutic Benefits
100%
Monocytes
100%
Tumor Necrosis Factor-α
100%
Etanercept
42%
Sickle Cell Anemia
28%
Blood Cells
28%
Translational Research
14%
Pathophysiology
14%
Early Events
14%
Pulmonary Hypertension
14%
Endothelial Cells
14%
Inflammatory Biomarkers
14%
Cell Wall
14%
Ischemia-reperfusion Injury
14%
Right Ventricular
14%
Transfusion
14%
Blood Biomarkers
14%
Anakinra
14%
Surrogate Marker
14%
Inflammatory Mediators
14%
Infliximab
14%
Vascular Cell Adhesion molecule-1 (VCAM-1)
14%
Beneficial Effects
14%
Liver Injury
14%
Blood Monocytes
14%
Systolic Pressure
14%
Vascular Wall
14%
Anti-neuroinflammation
14%
Early Growth Response Protein 1 (EGR1)
14%
Hypoxia-reoxygenation
14%
Tissue Factor
14%
Vascular Stasis
14%
Low Platelet Count
14%
Therapeutic Study
14%
Monocyte Activation
14%
Hemin
14%
Multiple Disturbances
14%
Tissue Production
14%
Muscularization
14%
Tumor Necrosis Factor-α Blocker
14%
IL-1 Blockers
14%
Vessel Cell
14%
Medicine and Dentistry
Transgenic Mouse
100%
Tumor Necrosis Factor
100%
Etanercept
37%
Sickle-Cell Disease
25%
Biological Marker
12%
Mediator
12%
Pathophysiology
12%
Hypoxia
12%
Translational Research
12%
Pulmonary Hypertension
12%
Endothelial Cell
12%
Liver Injury
12%
Reperfusion Injury
12%
Infusion
12%
Anakinra
12%
Systolic Blood Pressure
12%
Interleukin 1
12%
Vascular Cell Adhesion Molecule 1
12%
Blood Cell
12%
Disease Marker
12%
Thromboplastin
12%
Inflammatory Mediator
12%
Low Platelet Count
12%
Hemin
12%
Fibrinogen
12%
Infliximab
12%
Pharmacology, Toxicology and Pharmaceutical Science
Transgenic Mouse
100%
Tumor Necrosis Factor
100%
Etanercept
37%
Sickle Cell Anemia
25%
Biological Marker
12%
Hypoxia
12%
Disease Marker
12%
Liver Injury
12%
Interleukin 1
12%
Vascular Cell Adhesion Molecule 1
12%
Reperfusion Injury
12%
Hemin
12%
Pathophysiology
12%
Inflammation
12%
Pulmonary Hypertension
12%
Fibrinogen
12%
Thromboplastin
12%
Infliximab
12%
Anakinra
12%
Immunology and Microbiology
Tumor Necrosis Factor
100%
Transgenic Mouse
100%
Etanercept
37%
Sickle Cell
25%
Mediator
25%
Hemocyte
12%
Reperfusion
12%
VCAM-1
12%
Systolic Blood Pressure
12%
Interleukin 1
12%
Platelet Count
12%
Infliximab
12%
Reoxygenation
12%
Anakinra
12%
Fibrinogen
12%
Thromboplastin
12%